UnitedHealth Group (NYSE:UNH) Stock Acquired Rep. Tim Moore

Key Points

• Representative Tim Moore of North Carolina disclosed the purchase of UnitedHealth Group (NYSE:UNH) shares, acquiring between $1,001 and $15,000 on July 21st.
• UnitedHealth Group's stock recently opened at $245.59, with a market cap of $222.78 billion and a P/E ratio of 10.64, while reporting $4.08 EPS for the last quarter, missing estimates.
• The company announced a quarterly dividend increase to $2.21, representing an annualized payout of $8.84 and a dividend yield of 3.6%.

Representative Tim Moore (R-North Carolina) recently bought shares of UnitedHealth Group Incorporated NYSE: UNH. In a filing disclosed on August 05th, the Representative disclosed that they had bought between $1,001 and $15,000 in UnitedHealth Group stock on July 21st.

Representative Tim Moore also recently made the following trade(s):

• Purchased $15,001 - $50,000 in shares of Krispy Kreme NASDAQ: DNUT on 7/30/2025.
• Purchased $15,001 - $50,000 in shares of Centene NYSE: CNC on 7/30/2025.
• Purchased $15,001 - $50,000 in shares of Harley-Davidson NYSE: HOG on 7/30/2025.
• Purchased $15,001 - $50,000 in shares of Verizon Communications NYSE: VZ on 7/29/2025.
• Purchased $15,001 - $50,000 in shares of Intel NASDAQ: INTC on 7/29/2025.
• Purchased $1,001 - $15,000 in shares of Krispy Kreme NASDAQ: DNUT on 7/29/2025.
• Purchased $15,001 - $50,000 in shares of Centene NYSE: CNC on 7/29/2025.
• Purchased $1,001 - $15,000 in shares of Centene NYSE: CNC on 7/22/2025.
• Purchased $15,001 - $50,000 in shares of Centene NYSE: CNC on 7/21/2025.
• Purchased $15,001 - $50,000 in shares of Centene NYSE: CNC on 7/18/2025.

UnitedHealth Group Trading Up 2.5%

UNH stock traded up $6.07 during midday trading on Friday, reaching $250.74. The company's stock had a trading volume of 10,146,688 shares, compared to its average volume of 18,404,546. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The stock has a market cap of $227.46 billion, a PE ratio of 10.86, a price-to-earnings-growth ratio of 1.62 and a beta of 0.43. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The business's 50-day simple moving average is $291.78 and its 200-day simple moving average is $406.04.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The firm had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%. The company's revenue for the quarter was up 12.9% compared to the same quarter last year. During the same period in the prior year, the business earned $6.80 earnings per share. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were paid a $2.21 dividend. The ex-dividend date of this dividend was Monday, June 16th. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a yield of 3.5%. UnitedHealth Group's payout ratio is 38.30%.

Insider Buying and Selling at UnitedHealth Group

In related news, CEO Stephen J. Hemsley bought 86,700 shares of the business's stock in a transaction that occurred on Friday, May 16th. The shares were acquired at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the completion of the purchase, the chief executive officer directly owned 679,493 shares in the company, valued at $196,081,295.01. The trade was a 14.63% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Kristen Gil bought 3,700 shares of the business's stock in a transaction that occurred on Thursday, May 15th. The shares were bought at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the purchase, the director owned 3,818 shares of the company's stock, valued at $1,035,327.06. This represents a 3,135.59% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders purchased 109,408 shares of company stock valued at $31,607,768 over the last 90 days. Insiders own 0.28% of the company's stock.

Institutional Trading of UnitedHealth Group

Institutional investors and hedge funds have recently made changes to their positions in the company. Marshall & Sterling Wealth Advisors Inc. bought a new position in UnitedHealth Group in the 4th quarter valued at approximately $26,000. Bayforest Capital Ltd increased its position in shares of UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after buying an additional 48 shares during the period. Aster Capital Management DIFC Ltd bought a new position in UnitedHealth Group during the fourth quarter worth $30,000. Clal Insurance Enterprises Holdings Ltd boosted its stake in UnitedHealth Group by 416.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after acquiring an additional 50 shares in the last quarter. Finally, IAG Wealth Partners LLC bought a new position in UnitedHealth Group during the first quarter worth $42,000. Institutional investors own 87.86% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on UNH shares. Piper Sandler dropped their price objective on shares of UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating on the stock in a report on Wednesday, July 30th. TD Securities restated a "hold" rating and set a $308.00 price objective (down from $520.00) on shares of UnitedHealth Group in a report on Monday, May 19th. UBS Group restated a "buy" rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Deutsche Bank Aktiengesellschaft lowered their price target on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating on the stock in a research note on Wednesday, May 14th. Finally, Robert W. Baird reiterated an "underperform" rating and issued a $198.00 price target (down from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Three research analysts have rated the stock with a sell rating, seven have given a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $366.52.

About Representative Moore

Timothy K. Moore (Republican Party) is a member of the U.S. House, representing North Carolina's 14th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Moore (Republican Party) ran for election to the U.S. House to represent North Carolina's 14th Congressional District. He won in the general election on November 5, 2024. Moore served as speaker of the House from 2015 to 2025. Timothy Moore earned his B.A. from the University of North Carolina-Chapel Hill in 1992 and his J.D. from the Oklahoma City University School of Law in 1995. His professional experience includes working as an attorney.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.